Yaser Abu El-sameed, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-331-3400 Fax: 812-332-7265 |
Dr. Eric Trueblood, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-331-3400 Fax: 812-332-7265 |
Kriti Lonial, Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-331-3400 Fax: 812-332-7265 |
Helen Renee Kirk, M.D. Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-331-3400 Fax: 812-332-7265 |
Karen Sayad, MD Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 2651 E Discovery Pkwy, Bloomington, IN 47408 Phone: 812-331-3400 |
Dr. Caitilin Kelly, M.D. Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 3161 S Highpoint Ln, Bloomington, IN 47401 Phone: 812-287-8788 Fax: 812-333-0725 |
News Archive
In December, Mayo Clinic, Denver Health, Intermountain Healthcare, Dartmouth-Hitchcock, Cleveland Clinic, and The Dartmouth Institute for Health Policy and Clinical Practice announced the formation of the High Value Healthcare Collaborative to improve health care, lower costs, and move best practices out to the national provider community. Today, they announced that eight major health systems will join the Collaborative.
The Cedars-Sinai Graduate Program in Biomedical Sciences and Translational Medicine will award its first diplomas to six students during a commencement ceremony June 11.
More than 36 million people globally are affected by type 1 diabetes (T1D), a lifelong disorder where insulin producing cells are attacked and destroyed by the immune system resulting in deficient insulin production that requires daily blood glucose monitoring and administration of insulin.
Oregon Health & Science University Knight Cancer Institute researchers found that the GRB7 gene drives an aggressive form of breast cancer and acts independently of the HER-2 gene, known to be a stimulator of breast cancer growth. Isolating the role of this gene could ultimately help fine-tune a patient's treatment and enable physicians to provide a more accurate prognosis.
› Verified 8 days ago